Business & Industry
ABEC Opens New Biopharmaceutical Manufacturing Facility in Wilson, North Carolina
ABEC is set to open a new manufacturing facility in Wilson, North Carolina, further strengthening its network of biopharmaceutical process equipment and consumables production. A ribbon-cutting ceremony to mark the occasion is scheduled for 24 September, with company leadership,...
Business & Industry
UK Review Recommends ‘L Plates’ for New Healthcare AIs
The National Commission into the Regulation of AI in Healthcare has delivered its long-awaited report, setting out a framework for deploying artificial intelligence tools within the National Health Service in a manner described as "safe, fast, and trusted."
Commissioned by...
Business & Industry
Hengrui Wins World-First Approval for Hetrombopag in Chemotherapy-Induced Thrombocytopenia
Jiangsu Hengrui Pharma has secured a landmark regulatory clearance in China for its oral thrombopoietin (TPO) receptor agonist hetrombopag, making it the first oral TPO agonist anywhere in the world to receive approval for chemotherapy-induced thrombocytopenia (CIT). The approval...
News
Why FDA 510(k) Clearance and EU CE MDR Certification Should Anchor Your Hearing Aid Sourcing Strategy
Introduction
For e-commerce platforms, hospital procurement directors, healthcare supply chain managers, and medical device importers, hearing aid sourcing has moved far beyond simple price-per-unit comparisons. The international medical device landscape now demands verifiable regulatory compliance, robust factory documentation, and data...
Business & Industry
Gilead Sciences Inaugurates Advanced Research Centre in California
Gilead Sciences has expanded its R&D infrastructure with a new 182,000-square-foot facility in Foster City dedicated to inflammation, oncology, and data science.
News
Research Peptide Quality: What Laboratories Need to Know
Research Peptides in Modern Drug Discovery: Quality, Purity, and Sourcing Standards
Peptides have been a part of research for many years. The way scientists handle peptides has changed a lot. New methods for making them, better tools to analyze them,...
News
Biomarkers, Second Opinion, and Immunotherapy Planning for Stage 4 Colon Cancer With Booking Health
In recent years, biomarkers have become an essential part of patient evaluation and are driving the overall therapeutic strategy. Accurate molecular profiling of the tumor before any intervention is an essential component of effective treatment planning for stage 4...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read














